Analgesics
Antiandrogens
Antihistamines
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Monoclonals
Mpro inhibitors
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchHydrogen PeroxideHydrogen Per.. (more..)
Metformin Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta Thermotherapy Meta
Melatonin Meta

All Studies   Meta Analysis       

Antiviral Mechanism and Clinical Benefits of Mouthwash Active Against SARS-CoV-2

Brito-Reia et al., Current Oral Health Reports, doi:10.1007/s40496-024-00368-1
Feb 2024  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
21st treatment shown to reduce risk in May 2021, now with p = 0.029 from 7 studies.
Lower risk for viral clearance.
No treatment is 100% effective. Protocols combine treatments.
5,300+ studies for 116 treatments. c19early.org
Review of antiviral mechanisms and clinical benefits of mouthwashes for SARS-CoV-2, including chlorhexidine (CHX), cetylpyridinium chloride (CPC), ethyl lauroyl arginate (ELA), hydrogen peroxide (HP), povidone-iodine (PVP-I), and anionic phthalocyanine derivative (APD).
Reviews covering hydrogen peroxide for COVID-19 include1-4.
Review covers chlorhexidine, cetylpyridinium chloride, hydrogen peroxide, povidone-iodine, and phthalocyanine.
Brito-Reia et al., 19 Feb 2024, peer-reviewed, 4 authors. Contact: veronicabr@usp.br.
This PaperHydrogen Per..All
DOI record: { "DOI": "10.1007/s40496-024-00368-1", "ISSN": [ "2196-3002" ], "URL": "http://dx.doi.org/10.1007/s40496-024-00368-1", "alternative-id": [ "368" ], "assertion": [ { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Accepted", "name": "accepted", "order": 1, "value": "1 February 2024" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "First Online", "name": "first_online", "order": 2, "value": "19 February 2024" }, { "group": { "label": "Declarations", "name": "EthicsHeading" }, "name": "Ethics", "order": 1 }, { "group": { "label": "Conflict of Interest", "name": "EthicsHeading" }, "name": "Ethics", "order": 2, "value": "The authors declare no competing interests." }, { "group": { "label": "Human and Animal Rights and Informed Consent", "name": "EthicsHeading" }, "name": "Ethics", "order": 3, "value": "This article does not contain any studies with human or animal subjects performed by any of the present authors." } ], "author": [ { "ORCID": "http://orcid.org/0000-0003-1352-5474", "affiliation": [], "authenticated-orcid": false, "family": "Reia", "given": "Verônica Caroline Brito", "sequence": "first" }, { "ORCID": "http://orcid.org/0000-0003-3367-483X", "affiliation": [], "authenticated-orcid": false, "family": "da Fonseca Orcina", "given": "Bernardo", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0003-3840-3633", "affiliation": [], "authenticated-orcid": false, "family": "Vilhena", "given": "Fabiano Vieira", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0002-0674-3759", "affiliation": [], "authenticated-orcid": false, "family": "da Silva Santos", "given": "Paulo Sérgio", "sequence": "additional" } ], "container-title": "Current Oral Health Reports", "container-title-short": "Curr Oral Health Rep", "content-domain": { "crossmark-restriction": false, "domain": [ "link.springer.com" ] }, "created": { "date-parts": [ [ 2024, 2, 19 ] ], "date-time": "2024-02-19T08:03:11Z", "timestamp": 1708329791000 }, "deposited": { "date-parts": [ [ 2024, 5, 1 ] ], "date-time": "2024-05-01T12:54:45Z", "timestamp": 1714568085000 }, "funder": [ { "DOI": "10.13039/501100002322", "award": [ "001" ], "doi-asserted-by": "publisher", "name": "Coordenação de Aperfeiçoamento de Pessoal de Nível Superior" } ], "indexed": { "date-parts": [ [ 2024, 5, 1 ] ], "date-time": "2024-05-01T13:10:44Z", "timestamp": 1714569044670 }, "is-referenced-by-count": 0, "issue": "2", "issued": { "date-parts": [ [ 2024, 2, 19 ] ] }, "journal-issue": { "issue": "2", "published-online": { "date-parts": [ [ 2024, 6 ] ] } }, "language": "en", "license": [ { "URL": "https://www.springernature.com/gp/researchers/text-and-data-mining", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2024, 2, 19 ] ], "date-time": "2024-02-19T00:00:00Z", "timestamp": 1708300800000 } }, { "URL": "https://www.springernature.com/gp/researchers/text-and-data-mining", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2024, 2, 19 ] ], "date-time": "2024-02-19T00:00:00Z", "timestamp": 1708300800000 } } ], "link": [ { "URL": "https://link.springer.com/content/pdf/10.1007/s40496-024-00368-1.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://link.springer.com/article/10.1007/s40496-024-00368-1/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://link.springer.com/content/pdf/10.1007/s40496-024-00368-1.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "297", "original-title": [], "page": "138-143", "prefix": "10.1007", "published": { "date-parts": [ [ 2024, 2, 19 ] ] }, "published-online": { "date-parts": [ [ 2024, 2, 19 ] ] }, "publisher": "Springer Science and Business Media LLC", "reference": [ { "DOI": "10.1016/j.cell.2020.02.052", "author": "M Hoffmann", "doi-asserted-by": "publisher", "first-page": "271", "issue": "2", "journal-title": "Cell", "key": "368_CR1", "unstructured": "Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271-280.e8. https://doi.org/10.1016/j.cell.2020.02.052.", "volume": "181", "year": "2020" }, { "DOI": "10.3389/fmed.2020.580796", "author": "M Zhong", "doi-asserted-by": "publisher", "first-page": "580796", "journal-title": "Front Med (Lausanne)", "key": "368_CR2", "unstructured": "Zhong M, Lin B, Pathak JL, et al. ACE2 and furin expressions in oral epithelial cells possibly facilitate COVID-19 infection via respiratory and fecal-oral routes. Front Med (Lausanne). 2020;7:580796. https://doi.org/10.3389/fmed.2020.580796.", "volume": "7", "year": "2020" }, { "DOI": "10.1111/cpr.12923", "author": "L Chen", "doi-asserted-by": "publisher", "first-page": "e12923", "issue": "12", "journal-title": "Cell Prolif", "key": "368_CR3", "unstructured": "Chen L, Zhao J, Peng J, et al. Detection of SARS-CoV-2 in saliva and characterization of oral symptoms in COVID-19 patients. Cell Prolif. 2020;53(12):e12923. https://doi.org/10.1111/cpr.12923.", "volume": "53", "year": "2020" }, { "DOI": "10.1038/s41591-021-01296-8", "author": "N Huang", "doi-asserted-by": "publisher", "first-page": "892", "issue": "5", "journal-title": "Nat Med", "key": "368_CR4", "unstructured": "Huang N, Pérez P, Kato T, et al. SARS-CoV-2 infection of the oral cavity and saliva. Nat Med. 2020;27(5):892–903. https://doi.org/10.1038/s41591-021-01296-8.", "volume": "27", "year": "2020" }, { "DOI": "10.1080/20002297.2020.1848135", "author": "BF Matuck", "doi-asserted-by": "publisher", "first-page": "1848135", "issue": "1", "journal-title": "J Oral Microbiol", "key": "368_CR5", "unstructured": "Matuck BF, Dolhnikoff M, Maia GV, et al. Periodontal tissues are targets for Sars-Cov-2: a post-mortem study. J Oral Microbiol. 2020;13(1):1848135. https://doi.org/10.1080/20002297.2020.1848135.", "volume": "13", "year": "2020" }, { "DOI": "10.1177/0022034520918518", "author": "J Xu", "doi-asserted-by": "publisher", "first-page": "989", "issue": "8", "journal-title": "J Dent Res", "key": "368_CR6", "unstructured": "Xu J, Li Y, Gan F, Du Y, Yao Y. Salivary glands: potential reservoirs for COVID-19 asymptomatic infection. J Dent Res. 2020;99(8):989. https://doi.org/10.1177/0022034520918518.", "volume": "99", "year": "2020" }, { "DOI": "10.1002/path.5679", "author": "BF Matuck", "doi-asserted-by": "publisher", "first-page": "239", "issue": "3", "journal-title": "J Pathol", "key": "368_CR7", "unstructured": "Matuck BF, Dolhnikoff M, Duarte-Neto AN, et al. Salivary glands are a target for SARS-CoV-2: a source for saliva contamination. J Pathol. 2021;254(3):239–43. https://doi.org/10.1002/path.5679.", "volume": "254", "year": "2021" }, { "DOI": "10.3390/jcm9041126", "author": "F Carrouel", "doi-asserted-by": "publisher", "first-page": "1126", "issue": "4", "journal-title": "J Clin Med", "key": "368_CR8", "unstructured": "Carrouel F, Conte MP, Fisher J, Gonçalves LS, Dussart C, Llodra JC, Bourgeois D. COVID-19: a recommendation to examine the effect of mouthrinses with β-cyclodextrin combined with citrox in preventing infection and progression. J Clin Med. 2020;9(4):1126. https://doi.org/10.3390/jcm9041126.", "volume": "9", "year": "2020" }, { "DOI": "10.1016/S0927-7757(02)00404-1", "author": "ZE Proverbio", "doi-asserted-by": "publisher", "first-page": "167", "journal-title": "Colloids Surfaces A: Physicochem Eng Asp", "key": "368_CR9", "unstructured": "Proverbio ZE, Bardavid SM, Arancibia EL, Schulz PC. Hydrophile–lipophile balance and solubility parameter of cationic surfactants. Colloids Surfaces A: Physicochem Eng Asp. 2003;214:167–71. https://doi.org/10.1016/S0927-7757(02)00404-1.", "volume": "214", "year": "2003" }, { "DOI": "10.1111/omi.12408", "author": "F D’Amico", "doi-asserted-by": "publisher", "first-page": "171", "issue": "3", "journal-title": "Mol Oral Microbiol", "key": "368_CR10", "unstructured": "D’Amico F, Moro M, Saracino M, Marmiere M, Cilona MB, Lloyd-Jones G, Zangrillo A. Efficacy of cetylpyridinium chloride mouthwash against SARS-CoV-2: a systematic review of randomized controlled trials. Mol Oral Microbiol. 2023;38(3):171–80. https://doi.org/10.1111/omi.12408.", "volume": "38", "year": "2023" }, { "DOI": "10.1016/j.jlr.2022.100208", "author": "Z Saud", "doi-asserted-by": "publisher", "first-page": "100208", "issue": "6", "journal-title": "J Lipid Res", "key": "368_CR11", "unstructured": "Saud Z, Tyrrell VJ, Zaragkoulias A, Protty MB, Statkute E, Rubina A, et al. The SARS-CoV2 envelope differs from host cells, exposes procoagulant lipids, and is disrupted in vivo by oral rinses. J Lipid Res. 2022;63(6):100208. https://doi.org/10.1016/j.jlr.2022.100208.", "volume": "63", "year": "2022" }, { "DOI": "10.1016/j.ajoms.2022.04.001", "author": "N Okamoto", "doi-asserted-by": "publisher", "first-page": "800", "issue": "6", "journal-title": "J Oral Maxillofac Surg Med Pathol", "key": "368_CR12", "unstructured": "Okamoto N, Saito A, Okabayashi T, Komine A. Virucidal activity and mechanism of action of cetylpyridinium chloride against SARS-CoV-2. J Oral Maxillofac Surg Med Pathol. 2022;34(6):800–4. https://doi.org/10.1016/j.ajoms.2022.04.001.", "volume": "34", "year": "2022" }, { "DOI": "10.1007/s15010-020-01563-9", "author": "CJ Seneviratne", "doi-asserted-by": "publisher", "first-page": "305", "issue": "2", "journal-title": "Infection", "key": "368_CR13", "unstructured": "Seneviratne CJ, Balan P, Ko KKK, Udawatte NS, Lai D, Ng DHL, et al. Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: randomized control trial in Singapore. Infection. 2021;49(2):305–11. https://doi.org/10.1007/s15010-020-01563-9.", "volume": "49", "year": "2021" }, { "DOI": "10.1080/20002297.2020.1794363", "author": "MS Moosavi", "doi-asserted-by": "publisher", "first-page": "1794363", "issue": "1", "journal-title": "J Oral Microbiol", "key": "368_CR14", "unstructured": "Moosavi MS, Aminishakib P, Ansari M. Antiviral mouthwashes: possible benefit for COVID-19 with evidence-based approach. J Oral Microbiol. 2020;12(1):1794363. https://doi.org/10.1080/20002297.2020.1794363.", "volume": "12", "year": "2020" }, { "DOI": "10.15644/asc54/4/10", "author": "T Testori", "doi-asserted-by": "publisher", "first-page": "431", "issue": "4", "journal-title": "Acta Stomatol Croat", "key": "368_CR15", "unstructured": "Testori T, Wang HL, Basso M, Bordini G, Dian A, Vitelli C, Miletic I, Del Fabbro M. COVID-19 and oral surgery: a narrative review of preoperative mouth rinses. Acta Stomatol Croat. 2020;54(4):431–41. https://doi.org/10.15644/asc54/4/10.", "volume": "54", "year": "2020" }, { "DOI": "10.1016/j.mehy.2020.110436", "author": "INR Reis", "doi-asserted-by": "publisher", "first-page": "110436", "journal-title": "Med Hypotheses", "key": "368_CR16", "unstructured": "Reis INR, do Amaral GCLS, das Mendoza AAH, Graças YT, Mendes-Correa MC, Romito GA, Pannuti CM. Can preprocedural mouthrinses reduce SARS-CoV-2 load in dental aerosols? Med Hypotheses. 2021;146:110436. https://doi.org/10.1016/j.mehy.2020.110436.", "volume": "146", "year": "2021" }, { "DOI": "10.1177/00220345900690030901", "author": "D Bernstein", "doi-asserted-by": "publisher", "first-page": "874", "issue": "3", "journal-title": "J Dent Res", "key": "368_CR17", "unstructured": "Bernstein D, Schiff G, Echler G, Prince A, Feller M, Briner W. In vitro virucidal effectiveness of a 0.12%-chlorhexidine gluconate mouthrinse. J Dent Res. 1990;69(3):874–6. https://doi.org/10.1177/00220345900690030901.", "volume": "69", "year": "1990" }, { "DOI": "10.3346/jkms.2020.35.e195", "author": "JG Yoon", "doi-asserted-by": "publisher", "first-page": "e195", "issue": "20", "journal-title": "J Korean Med Sci", "key": "368_CR18", "unstructured": "Yoon JG, Yoon J, Song JY, Yoon SY, Lim CS, Seong H, Noh JY, Cheong HJ, Kim WJ. Clinical significance of a high SARS-CoV-2 viral load in the saliva. J Korean Med Sci. 2020;35(20):e195. https://doi.org/10.3346/jkms.2020.35.e195.", "volume": "35", "year": "2020" }, { "DOI": "10.1016/j.heliyon.2021.e07346", "author": "FP Eduardo", "doi-asserted-by": "publisher", "first-page": "e07346", "issue": "6", "journal-title": "Heliyon", "key": "368_CR19", "unstructured": "Eduardo FP, Corrêa L, Heller D, Daep CA, Benitez C, Malheiros Z, Stewart B, Ryan M, Machado CM, Hamerschlak N, Rebello Pinho JR, Bezinelli LM. Salivary SARS-CoV-2 load reduction with mouthwash use: a randomized pilot clinical trial. Heliyon. 2021;7(6):e07346. https://doi.org/10.1016/j.heliyon.2021.e07346.", "volume": "7", "year": "2021" }, { "DOI": "10.1016/j.fct.2013.02.018", "author": "M Aznar", "doi-asserted-by": "publisher", "first-page": "363", "journal-title": "Food Chem Toxicol", "key": "368_CR20", "unstructured": "Aznar M, Gómez-Estaca J, Vélez D, Devesa D, Nerín C. Migrants determination and bioaccessibility study of ethyl lauroyl arginate (LAE) from a LAE-based antimicrobial food packaging material. Food Chem Toxicol. 2013;56:363–70. https://doi.org/10.1016/j.fct.2013.02.018.", "volume": "56", "year": "2013" }, { "DOI": "10.1111/jcpe.12428", "author": "JT Gallob", "doi-asserted-by": "publisher", "first-page": "740", "issue": "8", "journal-title": "J Clin Periodontol", "key": "368_CR21", "unstructured": "Gallob JT, Lynch M, Charles C, Ricci-Nittel D, Mordas C, Gambogi R, Revankar R, Mutti B, Labella R. A randomized trial of ethyl lauroyl arginate-containing mouthrinse in the control of gingivitis. J Clin Periodontol. 2015;42(8):740–7. https://doi.org/10.1111/jcpe.12428.", "volume": "42", "year": "2015" }, { "DOI": "10.1093/function/zqaa002", "doi-asserted-by": "publisher", "key": "368_CR22", "unstructured": "O’Donnell VB, Thomas D, Stanton R, Maillard JY, Murphy RC, Jones SA, et al. Potential role of oral rinses targeting the viral lipid envelope in SARS-CoV-2 infection. Function (Oxf). 2020;1(1):zqaa002. https://doi.org/10.1093/function/zqaa002." }, { "DOI": "10.3389/fmicb.2020.01351", "author": "G Dev Kumar", "doi-asserted-by": "publisher", "first-page": "1351", "journal-title": "Front Microbiol", "key": "368_CR23", "unstructured": "Dev Kumar G, Mishra A, Dunn L, Townsend A, Oguadinma IC, Bright KR, Gerba CP. Biocides and novel antimicrobial agents for the mitigation of coronaviruses. Front Microbiol. 2020;11:1351. https://doi.org/10.3389/fmicb.2020.01351.", "volume": "11", "year": "2020" }, { "DOI": "10.1038/s41368-020-0075-9", "author": "X Peng", "doi-asserted-by": "publisher", "first-page": "9", "issue": "1", "journal-title": "Int J Oral Sci", "key": "368_CR24", "unstructured": "Peng X, Xu X, Li Y, Cheng L, Zhou X, Ren B. Transmission routes of 2019-nCoV and controls in dental practice. Int J Oral Sci. 2020;12(1):9. https://doi.org/10.1038/s41368-020-0075-9.", "volume": "12", "year": "2020" }, { "DOI": "10.1111/jopr.13220", "author": "AS Bidra", "doi-asserted-by": "publisher", "first-page": "599", "issue": "7", "journal-title": "J Prosthodont", "key": "368_CR25", "unstructured": "Bidra AS, Pelletier JS, Westover JB, Frank S, Brown SM, Tessema B. Comparison of in vitro inactivation of SARS CoV-2 with hydrogen peroxide and povidone-iodine oral antiseptic rinses. J Prosthodont. 2020;29(7):599–603. https://doi.org/10.1111/jopr.13220.", "volume": "29", "year": "2020" }, { "DOI": "10.1007/s00784-020-03549-1", "author": "MJ Gottsauner", "doi-asserted-by": "publisher", "first-page": "3707", "issue": "10", "journal-title": "Clin Oral Investig", "key": "368_CR26", "unstructured": "Gottsauner MJ, Michaelides I, Schmidt B, Scholz KJ, Buchalla W, Widbiller M, Hitzenbichler F, Ettl T, Reichert TE, Bohr C, Vielsmeier V, Cieplik F. A prospective clinical pilot study on the effects of a hydrogen peroxide mouthrinse on the intraoral viral load of SARS-CoV-2. Clin Oral Investig. 2020;24(10):3707–13. https://doi.org/10.1007/s00784-020-03549-1.", "volume": "24", "year": "2020" }, { "DOI": "10.3390/v12050525", "author": "JA Encinar", "doi-asserted-by": "publisher", "first-page": "525", "issue": "5", "journal-title": "Viruses", "key": "368_CR27", "unstructured": "Encinar JA, Menendez JA. Potential drugs targeting early innate immune evasion of SARS-coronavirus 2 via 2′-O-methylation of viral RNA. Viruses. 2020;12(5):525. https://doi.org/10.3390/v12050525.", "volume": "12", "year": "2020" }, { "DOI": "10.3390/v13040643", "doi-asserted-by": "publisher", "key": "368_CR28", "unstructured": "Sharshov K, Solomatina M, Kurskaya O, Kovalenko I, Kholina E, Fedorov V, Meerovich G, Rubin A, Strakhovskaya M. The photosensitizer octakis(cholinyl)zinc phthalocyanine with ability to bind to a model spike protein leads to a loss of SARS-CoV-2 infectivity in vitro when exposed to far-red LED. Viruses. 2021;13(4):643. https://doi.org/10.3390/v13040643." }, { "DOI": "10.1016/j.mtphys.2022.100882", "doi-asserted-by": "publisher", "key": "368_CR29", "unstructured": "Sadraeian M, Zhang L, Aavani F, Biazar E, Jin D. Photodynamic viral inactivation assisted by photosensitizers. Mater Today Phys. 2022;(28). https://doi.org/10.1016/j.mtphys.2022.100882." }, { "DOI": "10.2147/CCIDE.S315419", "doi-asserted-by": "publisher", "key": "368_CR30", "unstructured": "•• Santos C, da Fonseca Orcina B, Brito Reia VC, et al. Virucidal activity of the antiseptic mouthwash and dental gel containing anionic phthalocyanine derivative: In vitro study. Clin Cosmet Investig Dent. 2021;13:269–74. https://doi.org/10.2147/CCIDE.S315419. An in vitro study revealed that APD mouthwash and dental gel reduced the viability of the SARS-CoV-2 virus particles." }, { "DOI": "10.3205/dgkh000395", "doi-asserted-by": "publisher", "key": "368_CR31", "unstructured": "Vilhena FV, Brito Reia VC, da Fonseca Orcina B, et al. The use of antiviral Phthalocyanine mouthwash as a preventive measure against COVID-19. GMS Hyg Infect Control. 2021;16:Doc24. https://doi.org/10.3205/dgkh000395." }, { "DOI": "10.21203/rs.3.rs-1097185/v1", "doi-asserted-by": "publisher", "key": "368_CR32", "unstructured": "Orcina BDF, Reia VCB, Santos CA, et al. Atividade antibacteriana e antifúngica de produtos intraorais contendo ftalocianina: estudo in vitro. Praça de Pesquisa; 2021. https://doi.org/10.21203/rs.3.rs-1097185/v1." }, { "key": "368_CR33", "unstructured": "Organização Mundial da Saúde. Gestão clínica da COVID-19: orientação provisória, 27 de maio de 2020. Organização Mundial da Saúde. 2020. https://iris.who.int/handle/10665/332196." }, { "DOI": "10.2147/CCIDE.S295423", "doi-asserted-by": "publisher", "key": "368_CR34", "unstructured": "da Fonseca Orcina B, Vilhena FV, Cardoso de Oliveira R, Marques da Costa Alves L, Araki K, Toma SH, et al. A phthalocyanine derivate mouthwash to gargling/rinsing as an option to reduce clinical symptoms of COVID-19: Case Series. Clin Cosmet Investig Dent. 2021;13:47–50. https://doi.org/10.2147/CCIDE.S295423." }, { "DOI": "10.4067/S0718-381X2021000100067", "author": "B da Fonseca Orcina", "doi-asserted-by": "publisher", "first-page": "67", "issue": "1", "journal-title": "Int J Odontostomat", "key": "368_CR35", "unstructured": "da Fonseca Orcina B, Santos PSS. Oral manifestation COVID-19 and the rapid resolution of symptoms post-phtalox treatment: a case series. Int J Odontostomat. 2021;15(1):67–70.", "volume": "15", "year": "2021" }, { "key": "368_CR36", "unstructured": "Centers for Disease Control and Prevention (CDC) SARS-CoV-2 variant classifications and definitions. Atlanta: CDC. 2021. https://www.cdc.gov/coronavirus/2019-ncov/variants." }, { "DOI": "10.31744/einstein_journal/2021CE6999", "doi-asserted-by": "publisher", "key": "368_CR37", "unstructured": "•• Vilhena FV, da Fonseca Orcina B, Lemos L, Less JCF, Pinto I, da Silva Santos PS. Elimination of SARS-CoV-2 in nasopharynx and oropharynx after use of an adjuvant gargling and rinsing protocol with an antiseptic mouthwash. Einstein (São Paulo). 2022;19:eCE6999. https://doi.org/10.31744/einstein_journal/2021CE6999. Use of phthalocyanine derivative mouthwash caused the elimination of the SARS-CoV-2 virus in different strains." }, { "DOI": "10.21203/rs.3.rs-1065834/v1", "doi-asserted-by": "publisher", "key": "368_CR38", "unstructured": "• Reia VCB, Bastos RS, Vilhena FV, et al. Population-based virucidal phthalocyanine gargle/rinse protocol to reduce the risk of coronavirus disease-2019: a community trial. Res Sq [Preprint]. 2021. https://doi.org/10.21203/rs.3.rs-1065834/v1. The use of the APD mouthwash protocol appears to lower the population-level incidence of COVID-19." }, { "DOI": "10.1038/s41598-021-99013-5", "doi-asserted-by": "publisher", "key": "368_CR39", "unstructured": "•• da Silva Santos PS, da Fonseca Orcina B, Machado RRG, Vilhena FV, da Costa Alves LM, Zangrando MSR, et al. Beneficial effects of a mouthwash containing an antiviral phthalocyanine derivative on the length of hospital stay for COVID-19: randomised trial. Sci Rep. 2021;11(1):19937. https://doi.org/10.1038/s41598-021-99013-5. Using mouthwashes with a substance that has antiviral effects against the SARS-CoV-2 virus, according to a randomized clinical trial, can reduce patients' symptoms and the spread of infection." }, { "DOI": "10.21203/rs.3.rs-1139111/v1", "doi-asserted-by": "publisher", "key": "368_CR40", "unstructured": "Poleti ML, Gregório D, Bistaffa AGI, et al. The use of a mouthwash and a dentifrice containing antimicrobial phthalocyanine derivative on the reduction of clinical symptoms of COVID-19: a randomized triple-blinded clinical trial. Res Sq [Preprint]. 2021. https://doi.org/10.21203/rs.3.rs-1139111/v1." }, { "DOI": "10.1159/000246027", "author": "R Kawana", "doi-asserted-by": "publisher", "first-page": "29", "issue": "2", "journal-title": "Dermatology", "key": "368_CR41", "unstructured": "Kawana R, Kitamura T, Nakagomi O, Matsumoto I, Arita M, Yoshihara N, Yanagi K, Yamada A, Morita O, Yoshida Y, Furuya Y, Chiba S. Inactivation of human viruses by povidone-iodine in comparison with other antiseptics. Dermatology. 1997;195(2):29–35. https://doi.org/10.1159/000246027.", "volume": "195", "year": "1997" }, { "DOI": "10.1159/000057722", "author": "T Nagatake", "doi-asserted-by": "publisher", "first-page": "32", "issue": "1", "journal-title": "Dermatology", "key": "368_CR42", "unstructured": "Nagatake T, Ahmed K, Oishi K. Prevention of respiratory infections by povidone-iodine gargle. Dermatology. 2002;204(1):32–6. https://doi.org/10.1159/000057722.", "volume": "204", "year": "2002" }, { "DOI": "10.1007/s40121-020-00316-3", "author": "DE Anderson", "doi-asserted-by": "publisher", "first-page": "669", "issue": "3", "journal-title": "Infect Dis Ther", "key": "368_CR43", "unstructured": "Anderson DE, Sivalingam V, Kang AEZ, Ananthanarayanan A, Arumugam H, Jenkins TM, Hadjiat Y, Eggers M. Povidone-iodine demonstrates rapid in vitro virucidal activity against SARS-CoV-2, the virus causing COVID-19 disease. Infect Dis Ther. 2020;9(3):669–75. https://doi.org/10.1007/s40121-020-00316-3.", "volume": "9", "year": "2020" }, { "DOI": "10.1038/s41415-020-1794-1", "author": "P Hassandarvish", "doi-asserted-by": "publisher", "first-page": "900", "issue": "12", "journal-title": "Br Dent J", "key": "368_CR44", "unstructured": "Hassandarvish P, Tiong V, Sazaly AB, Mohamed NA, Arumugam H, Ananthanarayanan A, Qasuri M, Hadjiat Y. Povidone iodine gargle and mouthwash. Br Dent J. 2020;228(12):900. https://doi.org/10.1038/s41415-020-1794-1.", "volume": "228", "year": "2020" }, { "DOI": "10.1111/odi.13526", "doi-asserted-by": "publisher", "key": "368_CR45", "unstructured": "Martinez Lamas L, Diz Dios P, Perez Rodriguez MT, Del Campo P, Cabrera Alvargonzalez JJ, Lopez Dominguez AM, Fernandez Feijoo J, Diniz Freitas M, Limeres Posse J. Is povidone-iodine mouthwash effective against SARS-CoV-2? First in vivo tests. Oral Dis. 2020. [epub ahead of print 2 Jul 2020]. https://doi.org/10.1111/odi.13526." }, { "DOI": "10.1128/AAC.00576-20", "author": "X Mao", "doi-asserted-by": "publisher", "first-page": "e00576", "issue": "8", "journal-title": "Antimicrob Agents Chemother", "key": "368_CR46", "unstructured": "Mao X, Auer DL, Buchalla W, Hiller KA, Maisch T, Hellwig E, Al-Ahmad A, Cieplik F. Cetylpyridinium chloride: mechanism of action, antimicrobial efficacy in biofilms, and potential risks of resistance. Antimicrob Agents Chemother. 2020;64(8):e00576-e620. https://doi.org/10.1128/AAC.00576-20.", "volume": "64", "year": "2020" }, { "DOI": "10.1177/0022034520914246", "author": "L Meng", "doi-asserted-by": "publisher", "first-page": "481", "issue": "5", "journal-title": "J Dent Res", "key": "368_CR47", "unstructured": "Meng L, Hua F, Bian Z. Coronavirus disease 2019 (COVID-19): emerging and future challenges for dental and oral medicine. J Dent Res. 2020;99(5):481–7. https://doi.org/10.1177/0022034520914246.", "volume": "99", "year": "2020" }, { "DOI": "10.1111/idh.12402", "author": "BWM Van Swaaij", "doi-asserted-by": "publisher", "first-page": "27", "issue": "1", "journal-title": "Int J Dent Hyg", "key": "368_CR48", "unstructured": "Van Swaaij BWM, van der Weijden GAF, Bakker EWP, Graziani F, Slot DE. Does chlorhexidine mouthwash, with an anti-discoloration system, reduce tooth surface discoloration without losing its efficacy? A systematic review and meta-analysis. Int J Dent Hyg. 2020;18(1):27–43. https://doi.org/10.1111/idh.12402.", "volume": "18", "year": "2020" }, { "key": "368_CR49", "unstructured": "How Does COVIXYL-V Nasal Spray Work? Available online: https://salvacion-usa.com/facts-about-salvacions-product. Accessed 14 Jun 2023." }, { "DOI": "10.3390/pharmaceutics13101612", "author": "B Pilicheva", "doi-asserted-by": "publisher", "first-page": "1612", "issue": "10", "journal-title": "Pharmaceutics", "key": "368_CR50", "unstructured": "Pilicheva B, Boyuklieva R. Can the nasal cavity help tackle COVID-19? Pharmaceutics. 2021;13(10):1612. https://doi.org/10.3390/pharmaceutics13101612.", "volume": "13", "year": "2021" } ], "reference-count": 50, "references-count": 50, "relation": {}, "resource": { "primary": { "URL": "https://link.springer.com/10.1007/s40496-024-00368-1" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Antiviral Mechanism and Clinical Benefits of Mouthwash Active Against SARS-CoV-2", "type": "journal-article", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "volume": "11" }
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit